Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Shukra Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

76/99

BSE: 524632 | NSE: Not Listed

Watchlist

NSE BSE

84.75

19-Apr-2024

Open
High
Low
Previous Close

84.75
84.75
84.75
332.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

23
4.79
97.00
17.13

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

371.10
20.03
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

364.02
0.59%
1.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

29.51
59.72
73.83

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
26.57
29.89

PAT CAGR (%)

10 Years
5 Years
3 Years

-
57.16
185.25

P:E (Median)

8 Years
5 Years
3 Years

21.64
26.68
29.58

P:BV (Average)

8 Years
5 Years
3 Years

1.82
1.82
2.26

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.11
12.05
14.12

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 18.89 2.30 721.30% 24.64 3.72 562.37% 20.16 6.57 206.85% 46.25 8.94 417.34%
Expenses 9.35 2.02 362.87% 19.55 3.25 501.54% 19.82 5.61 253.30% 42.59 7.36 478.67%
EBITDA 9.54 0.29 3,189.66% 5.09 0.47 982.98% 0.34 0.95 -64.21% 3.65 1.57 132.48%
EBIDTM 50.52% 12.42% 20.65% 12.66% 1.67% 14.51% 7.90% 17.61%
Other Income 0.56 0.27 107.41% 0.24 0.03 700.00% 0.63 0.01 6,200.00% 0.89 0.04 2,125.00%
Interest 0.07 0.05 40.00% 0.07 0.04 75.00% 0.09 0.12 -25.00% 0.07 0.21 -66.67%
Depreciation 0.51 0.46 10.87% 0.56 0.45 24.44% 0.46 0.42 9.52% 0.51 0.56 -8.93%
PBT 9.53 0.05 18,960.00% 4.70 0.01 46,900.00% 0.43 0.42 2.38% 3.96 0.85 365.88%
Tax 0.11 0.02 450.00% -0.01 -0.07 - 0.01 0.10 -90.00% -0.01 0.20 -
PAT 9.42 0.03 31,300.00% 4.71 0.08 5,787.50% 0.42 0.33 27.27% 3.98 0.65 512.31%
PATM 49.87% 1.13% 19.12% 2.02% 2.09% 4.98% 8.60% 7.23%
EPS 8.64 0.02 43,100.00% 4.32 0.07 6,071.43% 0.39 0.30 30.00% 3.65 0.59 518.64%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 109.94 58.83 20.49 11.20 11.85 5.66 5.34 5.14 4.83 2.58 4.43 Net Sales Growth 410.64% 187.12% 82.95% -5.49% 109.36% 5.99% 3.89% 6.42% 87.21% -41.76% Cost Of Goods Sold 82.40 45.32 10.35 2.77 3.00 0.99 0.96 1.04 1.75 0.89 3.11 Gross Profit 27.54 13.52 10.14 8.43 8.84 4.67 4.39 4.09 3.07 1.69 1.32 GP Margin 25.05% 22.98% 49.49% 75.27% 74.60% 82.51% 82.21% 79.57% 63.56% 65.50% 29.80% Total Expenditure 91.31 53.47 17.60 9.75 10.31 4.01 3.73 3.67 3.64 2.82 4.52 Power & Fuel Cost - 0.00 0.00 1.78 1.64 0.34 0.29 0.26 0.26 0.28 0.17 % Of Sales - 0% 0% 15.89% 13.84% 6.01% 5.43% 5.06% 5.38% 10.85% 3.84% Employee Cost - 4.41 4.57 3.75 4.34 1.91 1.23 1.05 1.13 1.19 0.81 % Of Sales - 7.50% 22.30% 33.48% 36.62% 33.75% 23.03% 20.43% 23.40% 46.12% 18.28% Manufacturing Exp. - 0.12 0.09 0.05 0.03 0.02 0.02 0.02 0.00 0.01 0.03 % Of Sales - 0.20% 0.44% 0.45% 0.25% 0.35% 0.37% 0.39% 0% 0.39% 0.68% General & Admin Exp. - 3.36 2.50 1.35 1.29 0.73 1.22 1.12 0.32 0.44 0.26 % Of Sales - 5.71% 12.20% 12.05% 10.89% 12.90% 22.85% 21.79% 6.63% 17.05% 5.87% Selling & Distn. Exp. - 0.01 0.01 0.04 0.00 0.02 0.02 0.18 0.18 0.01 0.14 % Of Sales - 0.02% 0.05% 0.36% 0% 0.35% 0.37% 3.50% 3.73% 0.39% 3.16% Miscellaneous Exp. - 0.26 0.07 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.14 % Of Sales - 0.44% 0.34% 0.09% 0.08% 0% 0% 0% 0.21% 0% 0.23% EBITDA 18.62 5.36 2.89 1.45 1.54 1.65 1.61 1.47 1.19 -0.24 -0.09 EBITDA Margin 16.94% 9.11% 14.10% 12.95% 13.00% 29.15% 30.15% 28.60% 24.64% -9.30% -2.03% Other Income 2.32 1.20 0.08 0.36 0.01 0.04 0.11 0.07 0.19 1.12 0.20 Interest 0.30 0.28 0.29 0.03 0.00 0.00 0.04 0.01 0.00 0.00 0.01 Depreciation 2.04 1.84 1.66 1.47 1.48 0.96 0.74 0.47 0.45 0.60 0.78 PBT 18.62 4.44 1.02 0.29 0.07 0.72 0.95 1.06 0.92 0.27 -0.69 Tax 0.10 0.04 0.27 -0.09 0.14 0.26 0.42 0.56 0.23 0.14 0.06 Tax Rate 0.54% 0.90% 26.47% -100.00% 82.35% 36.11% 44.21% 52.83% 65.71% 51.85% -8.57% PAT 18.53 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 0.13 -0.76 PAT before Minority Interest 18.53 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 0.13 -0.76 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.85% 7.50% 3.66% 1.70% 0.34% 8.13% 9.93% 9.73% 2.48% 5.04% -17.16% PAT Growth 1,600.00% 488.00% 294.74% 375.00% -91.30% -13.21% 6.00% 316.67% -7.69% - EPS 17.00 4.05 0.69 0.17 0.04 0.42 0.49 0.46 0.11 0.12 -0.70

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 25.30 16.35 15.60 15.41 15.38 15.01 14.58 14.07 13.95 13.82 Share Capital 3.91 1.57 1.57 1.57 1.57 1.57 1.57 1.57 1.57 1.57 Total Reserves 21.38 14.78 14.03 13.85 13.81 13.44 13.01 12.51 12.39 12.26 Non-Current Liabilities 7.16 6.39 12.97 11.15 9.02 6.43 2.64 2.48 3.48 2.46 Secured Loans 0.90 0.85 0.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 2.87 2.28 9.11 8.05 6.06 3.58 0.04 0.04 1.20 0.31 Long Term Provisions 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 42.51 12.38 7.03 6.99 4.00 2.66 1.72 0.73 0.88 1.96 Trade Payables 34.25 8.59 5.33 6.46 3.15 1.93 1.14 0.52 0.71 1.78 Other Current Liabilities 8.15 3.47 0.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.10 0.32 0.77 0.52 0.85 0.73 0.58 0.21 0.17 0.17 Total Liabilities 74.97 35.12 35.60 33.55 28.40 24.10 18.94 17.28 18.31 18.24 Net Block 20.23 17.58 17.69 17.38 15.60 14.12 10.09 9.67 9.72 9.58 Gross Block 39.55 35.08 33.53 31.74 28.51 26.06 21.30 20.41 20.01 19.27 Accumulated Depreciation 19.32 17.50 15.83 14.36 12.90 11.94 11.20 10.74 10.29 9.69 Non Current Assets 21.89 19.24 19.55 19.09 17.32 15.83 11.86 11.40 11.44 11.29 Capital Work in Progress 1.66 1.66 1.66 1.66 1.66 1.66 1.72 1.68 1.68 1.66 Non Current Investment 0.00 0.00 0.19 0.05 0.05 0.05 0.04 0.04 0.03 0.05 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 53.07 15.87 16.06 14.45 11.07 8.27 7.08 5.88 6.87 6.95 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 3.16 3.95 1.68 1.39 0.27 0.14 0.32 0.44 1.35 1.14 Sundry Debtors 30.19 7.40 9.75 7.95 5.35 2.93 2.47 0.94 0.52 0.55 Cash & Bank 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 0.51 Other Current Assets 15.76 0.17 0.14 1.22 5.20 5.14 3.77 2.77 4.41 4.75 Short Term Loans & Adv. 7.79 4.06 3.98 3.77 3.59 3.51 3.35 2.32 4.40 4.75 Net Current Assets 10.57 3.50 9.03 7.47 7.08 5.61 5.36 5.15 6.00 5.00 Total Assets 74.96 35.11 35.61 33.54 28.39 24.10 18.94 17.28 18.31 18.24

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 3.17 7.99 0.54 1.24 0.26 0.84 -0.29 2.72 -2.03 -3.09 PBT 4.44 1.02 0.10 0.17 0.72 0.95 1.06 0.35 2.59 -0.70 Adjustment 1.60 1.91 1.44 1.58 0.96 0.77 0.47 0.45 0.05 0.60 Changes in Working Capital -2.62 5.50 -1.00 -0.51 -1.28 -0.74 -1.43 2.00 -4.47 -2.93 Cash after chg. in Working capital 3.42 8.43 0.54 1.24 0.41 0.98 0.10 2.79 -1.83 -3.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.00 0.00 Tax Paid -0.25 -0.44 0.00 0.00 -0.15 -0.18 -0.39 -0.08 0.01 -0.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.18 0.00 Cash From Investing Activity -4.43 -1.53 -1.89 -3.11 -2.45 -4.75 -0.93 -0.41 0.73 1.93 Net Fixed Assets -4.47 -1.55 -1.79 -3.23 -2.45 -4.70 -0.93 -0.40 -0.76 -1.89 Net Investments 0.00 0.19 -0.14 0.00 0.00 -0.01 0.00 -0.01 0.02 -0.04 Others 0.04 -0.17 0.04 0.12 0.00 -0.04 0.00 0.00 1.47 3.86 Cash from Financing Activity 4.94 -6.68 1.74 1.75 2.38 3.45 0.00 -1.16 1.38 1.60 Net Cash Inflow / Outflow 3.68 -0.21 0.38 -0.12 0.18 -0.46 -1.22 1.15 0.08 0.43 Opening Cash & Equivalents 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 0.51 0.08 Closing Cash & Equivalent 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 0.51

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 16.16 21.74 99.63 98.43 98.20 95.86 93.10 89.89 89.13 88.29 ROA 8.01% 2.12% 0.54% 0.11% 1.76% 2.44% 2.78% 0.67% 0.72% -4.80% ROE 21.16% 4.70% 1.21% 0.23% 3.04% 3.55% 3.51% 0.85% 0.94% -11.39% ROCE 18.85% 5.79% 0.54% 0.77% 3.62% 5.94% 7.41% 2.40% 1.83% -5.78% Fixed Asset Turnover 1.58 0.60 0.34 0.46 0.24 0.24 0.25 0.24 0.13 0.24 Receivable days 116.60 152.77 288.50 176.69 228.42 170.95 120.92 54.99 74.15 73.45 Inventory Days 22.06 50.20 50.01 22.02 11.47 14.59 26.67 67.13 171.85 94.74 Payable days 172.53 245.53 761.94 159.63 199.65 154.07 83.12 46.94 80.54 77.73 Cash Conversion Cycle -33.88 -42.56 -423.43 39.09 40.24 31.47 64.47 75.18 165.46 90.45 Total Debt/Equity 0.20 0.21 0.63 0.52 0.39 0.24 0.00 0.00 0.09 0.02 Interest Cover 16.82 4.55 3.94 84.02 1166.32 24.45 182.99 256.48 204.27 -48.20

Top Investors:

yogesh biharilal parikh

renuka yogesh parikh

Annual Reports:

News Update:

Shukra Pharma - Quarterly Results
12th Feb 2024, 17:46 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback